Conditions: Hypertension
Keywords: Hypertension
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 15
Healthy volunteers: no

Brief summary:
This study is being conducted to evaluate the safety and antihypertensive efficacy of MK-0954A (Losartan 50 mg / Hydrochlorothiazide (HCTZ) 12.5 mg) in participants with mild to moderate essential hypertension.

Detailed description:

Arms:
arm 1: Participants with mild to moderate essential hypertension who will receive Losartan 50 mg / HCTZ 12.5 mg once-a-day for 12 weeks.

Interventions: intervention 1: Losartan 50 mg / HCTZ 12.5 mg
Intervention descriptions: intervention 1: Losartan 50 mg / HCTZ 12.5 mg tablet once daily for 12 weeks

Protocol document: